Skydance vows 30 films/yr post-$110B Warner Bros deal, but theater owners fear fewer releases.

IBP's 11.2% gain beats S&P 500. Strong EPS growth but revenue may stall. Trades at 25.8x P/E.

JNJ, ABT, BDX: Dividend Kings with recurring revenue offer defensive healthcare plays, outperforming in downturns despite litigation risks.

YORW drops 5% on share dilution & discount pricing. Now at 52-week low, but offers potential value.

MGNI drops 26.9% to $13.38, but boasts 26.4% sales growth & 27.1% FCF margin. Trades at 11.8x forward P/E.

Fintech growth shines (35%+ revenue), but watch profits & valuation. PYPL trades 84% off peak!

Borr Drilling's 114% surge to $5.54 is tempered by negative FCF margin & subscale revenue. Valuation fair, but upside limited.